Goldman Sachs’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.81M Buy
2,511,676
+52,702
+2% +$59K ﹤0.01% 3199
2025
Q1
$1.94M Sell
2,458,974
-17,440
-0.7% -$13.8K ﹤0.01% 3388
2024
Q4
$4.09M Sell
2,476,414
-346,989
-12% -$573K ﹤0.01% 3007
2024
Q3
$9.88M Buy
2,823,403
+474,849
+20% +$1.66M ﹤0.01% 2273
2024
Q2
$7.7M Buy
2,348,554
+336,296
+17% +$1.1M ﹤0.01% 2300
2024
Q1
$14.8M Buy
2,012,258
+1,421,265
+240% +$10.4M ﹤0.01% 1758
2023
Q4
$2.21M Buy
590,993
+96,527
+20% +$361K ﹤0.01% 3135
2023
Q3
$1.05M Sell
494,466
-590,367
-54% -$1.25M ﹤0.01% 3509
2023
Q2
$5.16M Sell
1,084,833
-243,828
-18% -$1.16M ﹤0.01% 2549
2023
Q1
$7.57M Buy
1,328,661
+518,625
+64% +$2.96M ﹤0.01% 2220
2022
Q4
$8.17M Sell
810,036
-231,691
-22% -$2.34M ﹤0.01% 2273
2022
Q3
$23.3M Sell
1,041,727
-42,943
-4% -$962K 0.01% 1487
2022
Q2
$26.9M Buy
1,084,670
+858,193
+379% +$21.3M 0.01% 1400
2022
Q1
$8.78M Sell
226,477
-180,694
-44% -$7.01M ﹤0.01% 2345
2021
Q4
$23.8M Sell
407,171
-163,752
-29% -$9.58M ﹤0.01% 1633
2021
Q3
$33.8M Sell
570,923
-22,519
-4% -$1.33M 0.01% 1348
2021
Q2
$51.5M Sell
593,442
-226,100
-28% -$19.6M 0.01% 1059
2021
Q1
$67.6M Buy
819,542
+44,128
+6% +$3.64M 0.02% 820
2020
Q4
$70.5M Sell
775,414
-533,553
-41% -$48.5M 0.02% 732
2020
Q3
$52.3M Buy
1,308,967
+265,771
+25% +$10.6M 0.01% 832
2020
Q2
$35.8M Buy
1,043,196
+298,727
+40% +$10.2M 0.01% 1087
2020
Q1
$16.5M Buy
744,469
+69,032
+10% +$1.53M 0.01% 1449
2019
Q4
$13.2M Buy
675,437
+218,850
+48% +$4.28M ﹤0.01% 1884
2019
Q3
$7.09M Buy
456,587
+12,471
+3% +$194K ﹤0.01% 2125
2019
Q2
$9.02M Buy
444,116
+65,266
+17% +$1.32M ﹤0.01% 2001
2019
Q1
$6.66M Buy
378,850
+33,892
+10% +$595K ﹤0.01% 2260
2018
Q4
$4.43M Buy
344,958
+245,281
+246% +$3.15M ﹤0.01% 2408
2018
Q3
$1.62M Buy
99,677
+72,379
+265% +$1.18M ﹤0.01% 2972
2018
Q2
$310K Buy
+27,298
New +$310K ﹤0.01% 3712
2018
Q1
Sell
-50,966
Closed -$311K 4221
2017
Q4
$311K Sell
50,966
-75,260
-60% -$459K ﹤0.01% 3642
2017
Q3
$500K Buy
126,226
+14,451
+13% +$57.2K ﹤0.01% 3505
2017
Q2
$362K Sell
111,775
-32,278
-22% -$105K ﹤0.01% 3703
2017
Q1
$655K Buy
144,053
+119,200
+480% +$542K ﹤0.01% 3360
2016
Q4
$62K Sell
24,853
-10,564
-30% -$26.4K ﹤0.01% 4200
2016
Q3
$111K Sell
35,417
-549
-2% -$1.72K ﹤0.01% 4155
2016
Q2
$61K Sell
35,966
-137,958
-79% -$234K ﹤0.01% 4233
2016
Q1
$313K Buy
173,924
+147,233
+552% +$265K ﹤0.01% 3523
2015
Q4
$90K Buy
26,691
+11,894
+80% +$40.1K ﹤0.01% 4013
2015
Q3
$79K Buy
14,797
+2,547
+21% +$13.6K ﹤0.01% 4231
2015
Q2
$79K Sell
12,250
-24,763
-67% -$160K ﹤0.01% 4353
2015
Q1
$181K Sell
37,013
-36,423
-50% -$178K ﹤0.01% 3930
2014
Q4
$369K Sell
73,436
-10,256
-12% -$51.5K ﹤0.01% 3554
2014
Q3
$427K Buy
83,692
+15,815
+23% +$80.7K ﹤0.01% 3429
2014
Q2
$428K Buy
67,877
+41,567
+158% +$262K ﹤0.01% 3448
2014
Q1
$256K Sell
26,310
-14,681
-36% -$143K ﹤0.01% 3772
2013
Q4
$257K Buy
+40,991
New +$257K ﹤0.01% 3772